Skip to content
Screener

Indivior Pharmaceuticals, Inc. INDV Debt-to-equity

Debt-to-equity at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
0×0.0×
Alkermes logo
AlkermesALKS
0.9×+0.8×
TRV
Trevi Therapeutics, Inc.TRVI
0×0.0×
Emergent Biosolutions logo
Emergent BiosolutionsEBS
1.7×+0.5×

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.57B+66.3%
Enterprise value$4.9B+88.3%
P/E18.2×-7.2×
P/S3.5×+1.2×

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%—

Returns & leverage

See full
Return on equity-117%—
Current ratio0.9×0.0×